Lv2
130 积分 2024-11-28 加入
Community-Acquired Pneumonia in Adults
29天前
已完结
Associations between antibiotic use and outcomes in patients hospitalized with community-acquired pneumonia and positive respiratory viral assays
1个月前
已完结
Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin
1个月前
已完结
Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia
1个月前
已完结
Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response
3个月前
已完结
Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials
3个月前
已完结
Pneumococcal pneumonia trends in adults hospitalised with community-acquired pneumonia over 10 years (2013–2023) and the role of serotype 3
4个月前
已完结
Performance of various pneumonia severity models for predicting adverse outcomes in elderly inpatients with community-acquired pneumonia
4个月前
已完结
Incidence of community-acquired pneumonia in urban China: A national population-based study
4个月前
已完结
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation
4个月前
已完结
皖公网安备34019202002308
